Laser Eye Surgery

... ABC 7 News - After Eye Surgery,Guzman Sees a Brighter Year wjla.com web by News Weather Sports Olympics Scoreboard Baseball Hockey Golf Soccer Football Basketball NCAA Hoops Boxing NCAA Football Today In Sports Tennis Auto Racing WeatherBug Network ABC 7 eVideo GMW Greetings NewsLinks ABC 7 I-Team Inside Washington Capital Sunday Medical Reports Metro Traffic Talent Bios Legal Center My Profile Community Events Programming ABC 7 Classifieds Games Daily Horoscope Employment Lottery Results Home Page After Eye Surgery,Guzman Sees a Brighter Year Tuesday February 21, 2006 4:30pm Viera, Fla.

(AP) - After spending most of last season below the Mendoza Line, Cristian Guzman had his eyes fixed.

The first results are promising.

The Washington Nationals shortstop was an early arrival at spring training Tuesday and looked sharp in batting practice, having ditched contact lenses for laser surgery.

He claimed to be oblivious to the fact that the team has signed a veteran to contend for his job.

"They can bring here Jeter, I don't care," Guzman said.

"This is the new Guzie right now." Royce Clayton isn't exactly Derek Jeter, but he did hit .270 in 141 games last season with Arizona - 51 points better than Guzman's career-low .219.

The Nationals signed Clayton to a minor-league deal in case Guzma...

... PharmaLive: Diabetic Macular Edema trial with Retisert; Positive Results for pSivida REGISTERED USERS TRIAL RESULTS Diabetic Macular Edema trial with Retisert; Positive Results for pSivida PERTH, Australia & BOSTON-(BUSINESS WIRE)-Feb 21, 2006 - Global bio-nanotech company pSivida Limited (NASDAQ:PSDV)(ASX:PSD)(Xetra:PSI) today announced the publication of preliminary three year follow-up data from Bausch and Lomb's multi-center, randomized, controlled clinical trial of Retisert(TM) for the treatment of diabetic macular edema (DME).

Global eye health company, Bausch and Lomb (NYSE:BOL), exclusive licensee of Retisert(TM) from pSivida, conducted the study in hospitals in the United States in which 197 patients were randomized to receive either standard of care (repeat laser or observation) or a Retisert(TM) implant.

The study concluded that significantly more patients receiving a Retisert(TM) implant had improved visual acuity (of three or more lines on an eye chart) than those receiving standard of care.

DME, a common complication of Diabetic Retinopathy (DR), is the leading cause of vision loss in people under the age of 65 in the United States with an estimated 500,000 treatable cases.

DME is characterized by swelling of the retina and loss of vision.

Currently the only FDA approved treatment is laser therapy in which holes are burned into the macula with a laser.

This treatment is often ineffective or generally provides only temporary benefit.

There are no approved...

... /* GENERAL FONT AND LINK SETTINGS */ BODY, PRE, TR, TD, TH, P {font-family: Arial, Helvetica, sans-serif; font-size: small; color: #000000; font-weight: normal; font-style: normal} P {margin-top: 0px; margin-bottom: 1em} TH {font-weight: bold} .epi-fontSm, .wsui-font-small {font-size: x-small} .epi-font, .wsui-font {font-size: small} .epi-fontLg, .wsui-font-large {font-size: medium} a:link {color: #000066; text-decoration: underline} a:visited {color: #000066; text-decoration: underline} a:active, a:hover {color: #660000; text-decoration: underline} a.epi-headline {font-weight: normal; text-decoration: underline !

important} /* FOR TRAIL, PAGE, AND SECTION TITLES */ /* NAVIGATION TRAILS */ .epi-trail, .wsui-trail {font-family: Arial, Helvetica, sans-serif; font-size: small; color: #666666; font-weight: normal; margin-bottom: 0px} .epi-trail a, .wsui-trail a {color: #666666 !

important; text-decoration: none !

important} .epi-trail a:hover, .wsui-trail a:hover {color: #666666; text-decoration: underline !

important} .epi-trailOn, .wsui-trail-current {font-family: Arial, Helvetica, sans-serif; font-size: small; color: #000000; font-weight: bold; margin-bottom: 0px} /* PAGE TITLES */ h1, .epi-pageTitle, .wsui-page-title {font-family: Arial, Helvetica, sans-serif; font-size: medium; color: #663300; font-weight: bold; margin-bottom: 0px} /* SECTION TITLES*/ h2, .epi-sectionTitle, .wsui-section-title {font-family: Arial, Helvetica, sans-serif; font...